[Pathogenic bacteria in cystic fibrosis]

Area of Science:

• Pulmonary Medicine
• Infectious Diseases
• Genetics

Background:

• Bronchopulmonary infection significantly impacts cystic fibrosis (CF) prognosis despite advances in understanding the disease.
• Pseudomonas aeruginosa is a key pathogen following Staphylococcus aureus infection, contributing to lung deterioration in CF patients.
• Other bacteria such as Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes sp. can also be involved.

Purpose of the Study:

• To highlight the critical role of bacterial infections in cystic fibrosis (CF) patient outcomes.
• To emphasize the importance of timely and strategic antibiotic interventions.
• To discuss the necessity of long-term antibiotic strategies for managing chronic colonization and preventing antimicrobial resistance.

Main Methods:

• Review of current knowledge on CF pathophysiology and microbial colonization.
• Analysis of the impact of Staphylococcus aureus and Pseudomonas aeruginosa infections.
• Evaluation of antibiotic treatment strategies for primary and chronic colonization.

Main Results:

• Intensive antibiotic treatment for initial colonization can prevent or delay chronic bacterial presence.
• Chronic colonization requires a rational, long-term antibiotic approach to prevent multi-drug resistant organisms.
• Regular antibiotic treatments (every 3-4 months) are administered before symptom onset of pulmonary exacerbations.

Conclusions:

• Effective management of bronchopulmonary infections is paramount for CF patient survival.
• Early and strategic antibiotic use is essential to prevent chronic colonization and subsequent lung damage.
• Long-term antibiotic strategies are necessary to combat multiresistant bacteria and improve patient prognosis in cystic fibrosis.